We also demonstrate that the lipid-lowering effect of L-carnitine is associated with a reduction in the ER-associated ACSL1 in primary hepatocytes derived from NASH patients. This evidence concerns the gene ACSL1 and metabolic dysfunction-associated steatohepatitis.